ReviewAdvanced healthcare materials2026
How is Nanoarchitectonics Shaping Extracellular Vesicle Research?
Review in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Extracellular vesicles (EVs) have gained recognition as crucial mediators of cell-to-cell communication, holding immense potential in diverse biomedical applications. Nanoarchitectonics, a multidisciplinary approach encompassing nanotechnology and biomedicine, offers novel strategies for manipulating EVs at the nanoscale. This review explores the transformative influence of nanoarchitectonics on EVs research, focusing on the current progress in integrating various nanostructures to engineer EVs for enhanced therapeutic and diagnostic capabilities. The application of nanoarchitectonics has led to the fabrication of specialized nanostructures, such as plasmonic, fluorescent, magnetic, carbon-based, and organic-framework-based nanostructures designed explicitly for EVs research. This approach enables the engineering of EVs with improved targeting specificity, cargo loading efficiency, and therapeutic efficacy, thus advancing their potential in precision medicine. The review addresses the opportunities and challenges associated with the convergence of nanoarchitectonics and EVs research, underscoring the necessity for further optimization, rigorous safety assessments, and interdisciplinary collaboration. Finally, the review concludes by discussing the strengths and limitations of the nanoarchitectonics-EVs interface in nanomedicine and therapeutics, providing a strategic roadmap for future advancements in this rapidly evolving field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.